At the end of the study, prevalence of infection in the group receiving ART was approximately half that of the placebo group: 6.7% versus 11.6%, and incidence of new infection for the ART group was 2.7% versus 6.5% for the placebo group, i.e., a clearly significant risk reduction.
← all excerpts
Artemether and Praziquantel: Origin, Mode of Action, Impact, and Suggested Application for Effective Control of Human Schistosomiasis.
1
—
—